Discover trends, market shifts, and competitive outlooks for the rna sequencing services industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The RNA Sequencing Services Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, there’s been significant expansion in the market size of RNA sequencing services. The market, which stands at $3.58 billion in 2024, is predicted to rise to $4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.6%. The acceleration observed during the historic period is likely due to factors such as the rising demand for individualized treatment, improvement in bioinformatics tools, an amplified focus on the discovery and development of drugs, increased use of RNA sequencing for agricultural research, and its growing applications in the domain of clinical diagnostics.

The market size for RNA sequencing services is anticipated to experience accelerated expansion in the forthcoming years. It is predicted to escalate to $6.13 billion in 2029, with a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this increase during the forecast period include the rise of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning into data analysis, extension of research into non-coding RNA biomarkers, an escalating requirement for transcriptomic analysis in immunotherapy research, and burgeoning partnerships between academia and industry in genomic studies. Significant trends during the forecast period comprise the adoption of long-read sequencing, cloud-based analysis platforms, a surge in the need for RNA splicing analysis, and the integration of multi-omics data.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the RNA Sequencing Services Market?

The RNA sequencing services market is experiencing significant growth as a result of the increasing demand for personalized medicine. Personalized medicine aims to optimize treatment effectiveness and reduce adverse effects by customizing medical treatment based on individual characteristics like genetics or lifestyle. This increasing demand is driven by its promise of more effective treatments, advancements in genomics, growing complexity of diseases and regulatory support. RNA sequencing services play a crucial role in this scenario by identifying disease subtypes, discovering biomarkers, determining therapeutic targets, predicting responses to therapy, and tracking disease progression and treatment results. Personalized medicine leverages RNA sequencing technologies to develop customized medicines that cater to the particular molecular characteristics of each individual patient. For instance, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, stated that the FDA (Food and Drug Administration) had approved 16 new personalized therapies in 2023 for patients with rare diseases, compared to six in 2022. The newly approved 2023 personalized treatments included seven cancer drugs and three for other diseases and conditions. Therefore, the escalation in the demand for personalized medicine underpins the growth trajectory of the RNA sequencing services market.

Which Key Market Segments Comprise the RNA Sequencing Services Market and Drive Its Revenue Growth?

The RNA sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Which Areas Are Leading Regions in the RNA Sequencing Services Market Expansion Across the Globe?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theRNA Sequencing Services Market Over the Coming Years?

Prominent entities in the RNA sequencing services market, such as next-generation sequencing (NGS) assays, are moving towards automation to curtail possible human errors while enhancing effectiveness and preciseness in data creation and examination. The RNA Next Generation Sequencing (RNA-seq) assay serves as an efficacious instrument in the realms of genomics and molecular biology for evaluating the transcriptome of a biological specimen. As an illustration, Tempus, a U.S.-based precision medicine technology enterprise, introduced its exclusive RNA next-gen sequencing assay, Tempus xR in June 2023. Crafted for solid tumors, this pioneering assay enables a complete study of the transcriptome, emphasizing clinically significant fusions across over 100 targeted genes and altered splicing for MET exon 14 and EGFRvIII. Realizing the importance of RNA sequencing data, Tempus has traditionally included both RNA and DNA sequencing in its conventional xT broad-panel assay. Presently, clients can opt to order each test individually or in unison and can choose to enhance xR with select Tempus algorithmic exams. This service adjustment caters to doctors with a particular inclination towards RNA fusions or altered splicing, in addition to providers, researchers, and biopharmaceutical corporations seeking an exhaustive RNA sequencing examination of their current samples.

View the full report here:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

How Is the RNA Sequencing Services Market Conceptually Defined?

RNA sequencing is a high-throughput technique used to analyze the presence and quantity of RNA molecules within a sample, providing insights into gene expression levels and transcriptomic dynamics. It is used to explore gene expression patterns and regulatory mechanisms in many biological processes, such as development, illness, and response to stimuli.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model